Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8.

Saved in:
Bibliographic Details
Title: Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8.
Authors: Port, Andreas1 andreas.port@merckgroup.com, Shaw, Jamie V.2, Klopp-Schulze, Lena1, Bytyqi, Afrim1, Vetter, Claudia1, Hussey, Elizabeth3, Mammasse, Nadra4, Ona, Victor2, Bachmann, Angelika1, Strugala, Denis5, Reh, Christian5, Goteti, Kosalaram2
Source: Pharmacology Research & Perspectives. Oct2021, Vol. 9 Issue 5, p1-12. 12p.
Database: Academic Search Ultimate
Description
ISSN:20521707
DOI:10.1002/prp2.842